✓ Optic nerve sheath meningiomas (ONSMs) are rare tumors of the anterior visual pathway
and constitute approximately 2% of all orbital tumors and 1–2% of all meningiomas …

Optic nerve sheath meningiomas account for a third of all intrinsic tumours of the optic nerve.
Despite their classification as histologically benign tumours they cause progressive visual …

✓ Surgery is the mainstay for many patients with meningiomas, and it remains the standard.
In large single-institution series, gross-total resection has been reported to achieve 5-, 10 …

BACKGROUND: Traditional treatment options for optic nerve sheath meningiomas (ONSMs)
include observation, surgery, and radiotherapy, but to date none of these has become the …

Objective This study was aimed to review issues relating to the recognition, radiographic
diagnosis, monitoring, and management of primary and secondary optic nerve sheath …

Optic nerve sheath meningiomas (ONSM) are rare tumors of the meninges that surround the
optic nerve as it enters the orbit. If left untreated, these benign tumors lead to progressive …

PURPOSE: Radiotherapy has shown its efficacy in controlling optic nerve sheath
meningiomas (ONSM) tumor growth while allowing visual acuity to improve or stabilize …

PURPOSE: To provide the long-term outcomes of patients treated with fractionated
conformal radiotherapy (FCRT) for presumed optic nerve sheath meningiomas (ONSMs) …

✓ Optic nerve sheath meningiomas (ONSMs) are benign lesions originating from the dural
sheath of the optic nerve. Progressive growth can lead to gradual loss of vision and …

AIMS: To assess visual outcome, tumour control and treatment-related morbidity in patients
with optic nerve sheath meningiomas (ONSMs) treated with fractionated stereotactic …